NORTON HEALTHCARE LIMITED
Get an alert when NORTON HEALTHCARE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-24 (in 2mo)
Last made up 2025-07-10
Watchouts
Cash
777,000
-45.6% vs 2023
Net assets
525,108,000
+54.5% vs 2023
Employees
583
+1.9% vs 2023
Profit before tax
186,183,000
+556.6% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Name history
Renamed 1 time since incorporation
- NORTON HEALTHCARE LIMITED 1991-08-23 → present
- HARRIS PHARMACEUTICALS LIMITED 1969-02-13 → 1991-08-23
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £202,703,000 | £162,431,000 | |
| Operating profit | £20,644,000 | -£7,678,000 | |
| Profit before tax | -£40,780,000 | £186,183,000 | |
| Net profit | -£48,085,000 | £184,633,000 | |
| Cash | £1,427,000 | £777,000 | |
| Total assets less current liabilities | £360,637,000 | £542,604,000 | |
| Net assets | £339,826,000 | £525,108,000 | |
| Equity | £339,826,000 | £525,108,000 | |
| Average employees | 572 | 583 | |
| Wages | £40,351,000 | £43,897,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 10.2% | -4.7% | |
| Net margin | -23.7% | 113.7% | |
| Return on capital employed | 5.7% | -1.4% | |
| Gearing (liabilities / total assets) | 19.8% | 14.5% | |
| Current ratio | 4.49x | 4.37x | |
| Interest cover | 12.23x | -247.68x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors believe that preparing the financial statements on a going concern basis is appropriate due to the continued financial support of Teva Pharmaceuticals Europe B.V., a fellow group company. The directors have received confirmation from Teva Pharmaceuticals Europe B.V. that it has pledged its continuing support for a minimum of 12 months from the date of signing these financial statements.”
Significant events
- “On 5 November 2024, Teva UK Holdings Limited transferred the entire shareholdings of its subsidiary companies, which included that of Norton Healthcare Limited, to Teva Pharma Holdings Limited by way of a dividend in specie. Under the agreement, Teva UK Holdings Limited distributed to Teva Pharma Holdings Limited 90,253,000 ordinary shares of GBP 1.00 each in the capital of Norton Healthcare Limited. As a result of this transaction, the company became fully owned by Teva Pharma Holdings Limited.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 52 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BLACKBURN, Emma | Director | 2025-06-30 | Sep 1974 | British |
| CHARLESWORTH, Stephen Michael | Director | 2020-04-29 | Feb 1967 | British |
| STEVENS, Donna Colette | Director | 2026-04-22 | Apr 1974 | British |
Show 52 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GOODWIN, Trevor John | Secretary | — | 1999-03-26 |
| HORSMAN, Peter Brian | Secretary | 2006-04-07 | 2009-03-04 |
| LIVESEY, Ewan Murray | Secretary | 1999-03-26 | 2006-04-07 |
| PINSENT MASONS SECRETARIAL LIMITED | Corporate Secretary | 2017-03-13 | 2017-03-13 |
| ANDRIESSEN, Theodorus Jacobus | Director | 2006-02-28 | 2014-03-31 |
| ATKINSON, Nigel | Director | 2003-01-14 | 2003-12-31 |
| BAIN, Martyn Robert | Director | 1998-07-01 | 2002-04-06 |
| BECK, Cyril Harold | Director | — | 1993-01-29 |
| BEIGHTON, John | Director | 2006-02-28 | 2009-04-15 |
| BENNETT, Clive Ronald Reath | Director | 1994-12-01 | 1999-12-03 |
| BLACK, Ian | Director | — | 1993-09-30 |
| BLANKSBY, David Robert | Director | 2000-07-25 | 2002-04-18 |
| CLARK, Ian | Director | 1998-10-01 | 1999-04-29 |
| CLARK, Simon James | Director | 2002-06-25 | 2007-01-02 |
| CLOSE, Jon | Director | 1994-01-01 | 2000-07-25 |
| CONDELLA, Frank Charles | Director | 2002-08-12 | 2006-02-28 |
| COOKE, Terry | Director | 2025-07-14 | 2025-11-25 |
| COOPER, Dean Michael | Director | 2018-07-12 | 2020-04-29 |
| CUMMING, Kenneth Iain | Director | 2004-01-14 | 2006-04-07 |
| DESAI, Jeremy Bharat, Dr | Director | 2002-06-25 | 2003-01-14 |
| FAKES, David William, Dr | Director | 1995-05-01 | 2001-09-24 |
| FINNEGAN, Raymond | Director | 2020-05-26 | 2021-03-29 |
| FLANZRAICH, Neil William | Director | 1998-09-15 | 2006-01-26 |
| FORRESTER-COLES, Stephen Llanon | Director | 2009-03-04 | 2023-01-26 |
| FOSTER, Lynda | Director | 1994-01-01 | 1998-04-30 |
| FOSTER, Nicholas Mark | Director | 1997-04-01 | 2001-09-24 |
| GOODWIN, Trevor John | Director | 1993-02-15 | 1999-03-26 |
| HORSMAN, Peter Brian | Director | 2006-02-28 | 2009-03-04 |
| JOSEPHS, John Alexander | Director | 1994-01-01 | 1998-07-31 |
| KATZ, Margot Jane | Director | 1994-01-01 | 1997-06-27 |
| KAYE, Isaac | Director | — | 2003-06-12 |
| LIVESEY, Ewan Murray | Director | 2003-01-14 | 2006-03-31 |
| LONG, Nicolas Sharp | Director | 2001-02-27 | 2001-09-24 |
| LOUMEAU, Jean Francois | Director | 2003-04-01 | 2005-02-11 |
| MCCUBBIN, Ian | Director | 2002-03-19 | 2003-06-12 |
| MCCUBBIN, Ian | Director | 2001-02-27 | 2001-09-24 |
| MUKOMOLOV, Genady | Director | 2023-07-13 | 2025-06-30 |
| NOORDERMEER, Gertjan | Director | 2014-03-31 | 2014-09-09 |
| NORTON, Nigel Niman | Director | — | 1993-02-15 |
| O'GORMAN, Barbara | Director | 2002-03-19 | 2003-01-14 |
| O'GORMAN, Barbara | Director | 1998-05-01 | 2001-09-24 |
| ORESKOVIC, Tim | Director | 2014-09-09 | 2016-01-14 |
| PFENNIGER, Richard Charles | Director | — | 1997-03-04 |
| POSPISIL, Bohumir | Director | 2004-01-14 | 2006-04-07 |
| POTTS, Roland Gordon | Director | 2021-03-29 | 2025-07-31 |
| RUBIN, Steven Daniel | Director | 2002-05-15 | 2006-09-01 |
| SCHREWE, Michael | Director | 2014-01-30 | 2016-08-01 |
| STRATTON, Anthony Hugh | Director | 2002-02-12 | 2003-12-31 |
| TABERNILLA, Armando | Director | 1997-11-01 | 1998-08-14 |
| VRHOVEC, David | Director | 2017-04-07 | 2020-05-26 |
| WILLIAMS, Robert | Director | 2016-08-01 | 2018-06-27 |
| WILLIAMS, Robert | Director | 2009-03-04 | 2014-01-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Teva Pharma Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-11-05 | Active |
| Teva Uk Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-04-29 | Ceased 2024-11-05 |
| Ivax Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2021-04-29 |
Filing timeline
Last 20 of 269 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-27 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-27 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-07 | AA | accounts | Accounts with accounts type full | |
| 2025-07-31 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-28 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-16 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-07-15 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-08 | TM01 | officers | Termination director company with name termination date | |
| 2025-05-30 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-05-30 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2024-10-09 | AA | accounts | Accounts with accounts type full | |
| 2024-07-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-12-17 | AA | accounts | Accounts with accounts type full | |
| 2023-07-17 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-03 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-16 | AA | accounts | Accounts with accounts type full | |
| 2022-07-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-07-05 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-07-04 | PSC02 | persons-with-significant-control | Notification of a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 10
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-19.9%
£202,703,000 £162,431,000
-
Cash
-45.6%
£1,427,000 £777,000
-
Net assets
+54.5%
£339,826,000 £525,108,000
-
Employees
+1.9%
572 583
-
Operating profit
-137.2%
£20,644,000 -£7,678,000
-
Profit before tax
+556.6%
-£40,780,000 £186,183,000
-
Wages
+8.8%
£40,351,000 £43,897,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers